Rizvi N, et al. Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial. Abstract OA04.07. WCLC 2019, 7-10 september, Barcelona, Spanje.
Betere behandeling van prostaatkanker door combinatie van bestralingstechnieken
feb 2017 | Radiotherapie, Uro-oncologie